A Disease-Modifying Approach for Advanced Hidradenitis Suppurativa (Regimen with Metformin, Liraglutide, Dapsone, and Finasteride): A Case Report
Hidradenitis suppurativa (HS) is a challenging skin disease with limited therapeutic options. Obesity and metabolic syndrome are being increasingly implicated and associated with younger ages and greater metabolic severity. A 19-year-old female with an 8-year history of progressively debilitating ci...
Main Author: | Birgit N. Khandalavala |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2017-07-01
|
Series: | Case Reports in Dermatology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/473873 |
Similar Items
-
The Role of Hormones in Hidradenitis Suppurativa: A Systematic Review
by: Nessr Abu Rached, et al.
Published: (2022-12-01) -
Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data
by: Aikaterini Kyriakou, et al.
Published: (2018-10-01) -
Epidemiology of hidradenitis suppurativa in Poland in relation to international data
by: Łukasz Matusiak, et al.
Published: (2017-09-01) -
Metformin: A Potential Treatment for Acne, Hidradenitis Suppurativa and Rosacea
by: Minah Cho, et al.
Published: (2023-12-01) -
Correlation of Increased Total Serum Immunoglobulin E Levels and Hidradenitis Suppurativa
by: Ballova A, et al.
Published: (2021-03-01)